Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
The latest announcement is out from Vor Biopharma ( (VOR) ).
Vor Biopharma Inc. has welcomed Han Choi, M.D., LL.M., to their executive team as the new Chief Financial Officer effective September 30, 2024. Dr. Choi’s extensive background, including over twenty years at Oracle Investment Management and experience in healthcare investments, positions him as a significant asset to Vor Bio’s financial and strategic operations. His appointment is bolstered by an attractive compensation package, including a substantial base salary, performance-based bonuses, and an inducement stock option grant, all aimed at steering the company forward in the cell and genome engineering industry.
See more insights into VOR stock on TipRanks’ Stock Analysis page.
